To investigate whether old age frailty is predicted by midlife overweight/obesity and cardiovascular disease (CVD) risk. DESIGN: Longitudinal observational study (the Helsinki Businessmen Study). SUBJECTS: In their midlife in 1974, 1815 initially healthy men (mean age 47 years) were clinically investigated, whereupon their weight status (normal weighto25 kg m À 2 , overweight 25pbody mass index o30 kg m À 2 and obese X30 kg m À 2 ), CVD risk factors and a composite risk score (%) of coronary artery disease (CAD) were assessed. After a 26-year follow-up in 2000, when 425 men had died, the frailty status of survivors (80.9%, n ¼ 1125, mean age 73 years) was assessed using a postal questionnaire including the RAND-36/SF-36 instrument. Phenotypic criteria were used to define frailty, and according to these criteria, 40.0% (n ¼ 450), 50.4% (n ¼ 567) and 9.6% (n ¼ 108) were classified as not frail, prefrail and frail, respectively. Risks are presented as odds ratios (OR) with 95% confidence intervals (CI). RESULTS: Compared with normal weight, the development of frailty was significantly higher among those men who were overweight or obese in midlife, with fully adjusted ORs (95% CI) of 2.06 (1.21-3.52) and 5.41 (1.94-15.1), respectively. Even the development of prefrailty was significantly increased with midlife overweight (OR 1.39; 95% CI, 1.03-1.87) and obesity (OR 2.96; 95% CI,). Age-adjusted composite CAD score in midlife predicted similarly 26-year total mortality (OR per 1% increase:1.16; 95% CI, 1.08-1.24) and development of frailty (OR 1.16; 95% CI, 1.02-1.33). CONCLUSION: Overweight/obesity and higher CAD risk in midlife were associated with frailty 26 years later. Preventing old age frailty should be recognized as an important goal of obesity and CVD risk control.
INTRODUCTION
As an important predictor of disability, institutionalization and death, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] old age frailty will rise to a public health issue of remarkable proportions during the coming decades. Although no strict consensus criteria have been established to date, 2,7 the phenotypic criteria described by Fried et al. 1 are commonly used to define frailty as a geriatric syndrome characterized by excess vulnerability, loss of resiliency and multi-system decline. According to the phenotypic definition, frailty is not exclusively explained (albeit often accompanied) by disabilities or comorbidities. 4 In addition to definition, knowledge of the physiological processes leading to frailty is incomplete and more detailed understanding of risk factors for frailty is important for targeted preventive actions. 3, 5 In cross-sectional settings, or prospectively in later life, frailty has been associated with both clinical and subclinical cardiovascular disease (CVD). [11] [12] [13] Accelerated cardiovascular ageing 14 could be one explanation for the proposed relationship between frailty and CVD and also shared biological alterations, such as lowgrade inflammation, 15 may have a role. We have speculated earlier that development of frailty and weight loss therefore could also explain the 'obesity paradox' 16 -better prognosis among older people with overweight or obesity. In the present long-term analysis, we have related midlife weight status and CVD risk factors to phenotypic frailty in old age in our homogenous male cohort.
SUBJECTS AND METHODS

Study population
The study population of the Helsinki Businessmen Study has been described in detail previously. [16] [17] [18] [19] The research protocol of the follow-up has been approved by the Ethics Committee of the Department of Medicine, University of Helsinki, and informed consent was obtained from the participants. In brief, 3490 men, mostly business executives born between 1919 and 1934, participated in volunteer health check-ups during the 1960s and early 1970s organized by Finnish Institute of Occupational Health. At that time, they received health education to diminish their CVD risk. In 1974, the men were evaluated by questionnaires and clinical and laboratory examinations for a participation in a CVD prevention trial. 16 At that time, 1815 men with a mean age of 47 years were found to be without signs and symptoms of chronic diseases including CVD and without regular medications. However, majority of them had various CVD risk factors. Because preliminary analyses showed that participation in the prevention trial during the 1970s did not affect the present analyses 26 years later, all 1815 men were included to improve statistical power. 1 
Baseline risk factors
In 1974, several variables were measured to assess CVD risk. Body mass index (BMI) was calculated from clinic-measured weight and height as weight (kilograms) divided by height (meters) squared. Additionally, participants were asked to recall their weight at 25 years of age. Weight status was defined as normal weighto25 kg m À 2 , overweight 25pBMIo30 kg m À 2 and obese X30 kg m À 2 . Systolic and diastolic blood pressure (mm Hg) was registered after a 10-min rest with the subject in a sitting position and using a mercury sphygmomanometer. Fasting serum total cholesterol and triglyceride and fasting blood glucose levels were measured using standard methods. Smoking (cigarettes per day) and alcohol consumption (grams per week) were assessed with questionnaires. For statistical analyses, alcohol consumption was divided in three groups: 0, 1-349 g per week, 4349 g per week. 18 Blood glucose (mmol l À 1 ) was measured fasting and 1 h post load (1 g glucose per kg administered orally). In 1974, the composite risk score for coronary artery disease (CAD) was calculated according to the contemporary Keys' risk equation. 20 It takes into account age, systolic blood pressure, cholesterol, smoking and BMI, and gives the 5-year risk (%) of CAD among European men aged 40-59 years. The risk could not be assessed according to the Framingham equation because serum high-density lipoprotein cholesterol was not available. Detailed physical activity is available only of a subcohort at baseline, but the men were asked how they rated their physical fitness on a five-step scale ('very good', 'good', 'fair', 'poor', 'very poor'). This rating was closely related to physical activity (unpublished observations).
Follow-up
Mortality was comprehensively followed up using national central registers, and 425 men had died by the year 2000. The survivors (n ¼ 1390, mean age 73) were re-assessed using postal questionnaires, an average of 26 years since baseline. The questionnaire was re-sent once for non-respondents, and in all 1207 (87.9%) men responded. The questionnaire included items about anthropometric measures, living conditions, history and presence of chronic diseases, medication and lifestyle factors (for example, alcohol consumption, smoking). In addition, the Finnish version of the RAND-36-Item Health Survey 1.0 (practically the same as SF-36 and validated in the Finnish population) 21 was embedded into the questionnaire. From the responses, the Charlson comorbidity index 22 was calculated, taking into account the number and severity of comorbid conditions.
Frailty assessment
In this study, frailty status at follow-up was defined by a modification 19 of the method initially described in the Cardiovascular Health Study, and including shrinking, subjective exhaustion, physical inactivity, slow walking speed and physical weakness. 1 Because walking speed was not measured in our study in 2000, we used four criteria as follows: (1) Shrinking was defined as weight loss of X5% from midlife, or having current calculated BMI under 21 kg m The answer 'No' was taken to denote physical inactivity. The participant was classified to be frail or prefrail if 3-4 (9.6%, n ¼ 108), or 1-2 (50.4%, n ¼ 567) of the aforementioned criteria were met, respectively, and not frail (40.0%, n ¼ 450) if zero criteria were present. Frailty status could be assessed in 1125 community-living men out of 1207 responders (representing 80.9% of survivors in 2000), and these men formed the population of the present study. Among the 108 frail men, shrinking, physical weakness, exhaustion and physical inactivity were observed in 64.8%, 88.9%, 92.6% and 69.4%, respectively. We have reported earlier 19 that our frailty definition prospectively predicts important clinical endpoints (walking speed, mobility-disability and mortality) in our cohort.
Statistical analysis
The statistical software NCSS (version 2004, www.ncss.com, Kaysville, UT, USA) was used for the statistical analyses. The not frail, prefrail and frail groups in the year 2000 were defined as described above. T-tests, nonparametric tests and analyses of covariance were used where appropriate to compare continuous variables (mean with s.e. logarithmic transformation where appropriate) across frailty groups. Chi-square and trend tests were used to compare proportions. Multinomial logistic regression was used to find independent midlife predictors separately for old age prefrailty and frailty with not frail men as the referent group. Odds ratios (with their 95% confidence intervals) were calculated. Covariates were selected according to the difference (Po0.05) between the frailty groups in univariate comparisons. For the BMI covariate, normal weight (BMIo25 kg m À 2 ) was used as reference. In statistical analyses, two-sided P-valueso0.05 were taken as significant.
RESULTS
In old age in the year 2000, those men defined as frail were slightly older, had lower BMI, smoked more and had more comorbidity as compared with other groups. Accordingly, there was a significant difference in age (73 (s.e. 0. The midlife characteristics of the three groups in 1974, when all men were still active and without clinical diseases, are in Table 1 . The characteristics of those men who died before responding to the 2000 survey (n ¼ 425), or did not respond at all (n ¼ 183), are shown for comparison. Several CVD risk factors were significantly different in midlife between the frailty groups defined in old age. Although there was no difference in BMI at age 25 years between the groups, those participants classified as prefrail or frail in 2000 had gained more weight up to midlife than those who remained not frail. Consequently, the proportion of overweight men (25pBMIo30 kg m À 2 ) in 1974 was 49.6% (n ¼ 223), 59.8% (n ¼ 339) and 73.1% (n ¼ 79) in not frail, prefrail and frail men, respectively (Po0.001). The respective proportions of obese men (BMI X30 kg m À 2 ) were 3.1% (n ¼ 14), 7.6% (n ¼ 43) and 10.2% (n ¼ 11, Po0.001). Smoking in midlife had been more prevalent among those who later turned prefrail or frail, and there was also a significant trend towards higher midlife systolic blood pressure, heart rate, serum triglycerides and 1-h glucose with higher levels in the frailty category ( Table 1) . As a result, the age-adjusted composite CAD risk score in midlife was significantly different between the frailty groups in old age, 26 years later, and the highest value was found in frail men. Of note, several CVD risk factors in midlife had been similar among those who died before old age, or were frail in their eight decades of life (Table 1) .
We also compared mortality and the distribution of frailty states among survivors in 2000 according to the weight groups (normal weight, overweight and obese) at baseline. Not frail status at follow-up was most common in persons with normal weight at baseline (33.5%, 23.4% and 11.9% among those normal weight, overweight and obese, respectively, Po0.001), whereas frailty (4.1%, 7.6% and 9.3%, respectively) and lost to follow-up due to death (19.0%, 24.2% and 33.1%, respectively) was more prevalent in those being obese at baseline. There was no significant difference in the proportions of surviving non-respondents in 2000 between the midlife weight groups (9.8%, 10.4% and 8.5% in the normal weight, overweight and obese, respectively). There were only 9 men at baseline whose BMI was 35 kg m À 2 or higher. Of them, 4 men (44.4%) had died and only 1 (11.1%) was not frail in old age.
Multinomial logistic regression analysis was used to find independent midlife predictors of prefrailty and frailty in old age. Those midlife variables that differed (Po0.05) between the frailty groups (Table 1) were included in the analyses. The variables were tested as continuous (age, systolic blood pressure, resting heart rate, log triglycerides and log 1-h glucose), dichotomous (smoking) and three-step (BMI, normal weight as referent), and the results with all variables in the same model are in Table 2 . To find out whether the association between midlife CVD risk factors and frailty was driven by the development of comorbidities, we added the Charlson comorbidity index in the multinomial logistic regression analyses with the aforementioned risk factors (Table 3) . Comorbidity index was significantly associated with prefrailty and frailty, but the independent impact of midlife overweight and obesity remained.
In separate analyses, the odds ratios of the age-adjusted Keys' composite CAD risk score (per 1% increase) in midlife was 1.16 (95% confidence interval 1.08-1.24) and (1.16; 1.02-1.33), Table 2 . Multinomial logistic regression analyses of being prefrail and frail vs not frail in old age according to midlife characteristics 26 years earlier Odds ratio was calculated using multinomial logistic regression analysis. All covariates in the same model separately for prefrailty or frailty vs not frail. Other covariates included were systolic blood pressure, triglycerides (log-transformed), 1-h glucose (log-transformed), resting pulse rate and smoking. b Odds ratio was calculated using multinomial logistic regression analysis.
Frailty, obesity and cardiovascular risk TE Strandberg et al respectively, for 26-year total mortality and development of frailty in old age.
DISCUSSION
The results indicate that the development of frailty is a long-term process. Especially obesity, but also higher CAD risk among clinically healthy middle-aged men significantly predicted frailty in later life. It is thus paradoxical that those overweight and obese in midlife life may turn thin and frail in later years. Our findings further suggest that the reported coexistence of CVD and frailty 12, 13 is at least partly explained by shared risk factors, and not only secondary effects of disease. These long-term results are in accordance with cross-sectional and old age studies on associations between obesity, smoking and frailty, 23, 24 as well as with the Cardiovascular Health Study, 11 which showed that subclinical CVD was associated with frailty.
Because frailty is an increasing health problem in the aging societies, 1 these are important messages and add a new dimension to the obesity epidemic and also to CVD prevention. The strengths of our study include the exceptionally long followup from the clinically healthy midlife, and the homogenous population in which socioeconomic confounders are minimized.
Frailty, a 'syndrome of geriatric syndromes', has conventionally been considered a geriatric problem with treatment modalities related to contemporary procedures such as sufficient protein nutrition and adequate physical therapy. 10 Our long-term results strongly suggest that the prevention of frailty should be started much earlier than commonly realized. Physical activity throughout the life course, avoidance of smoking and midlife weight gain and appropriate treatment of CVD risk factors are instrumental in this, 10 and these are being recommended anyway. However, we argue that frailty would widen the scope of CVD and should therefore be recognized as an important clinical endpoint of CVD risk factors and obesity. This is illustrated in our study, which has the ability to compare the 'overall' fate of middle-aged men. If an obese middle-aged man survived up to 70 years, his risk of being prefrail or frail is very high.
Although the genetic basis of frailty is currently obscure, 25 there are several mechanisms that could mediate the relationship between CVD risk and frailty. Vascular dysfunction may simply worsen blood circulation and lead to sarcopenia, the core factor in frailty. Actually, sarcopenia has been cross-sectionally associated with atherosclerosis and vascular risk factors. [26] [27] [28] Important mediators may also include low-grade inflammation and coagulation disorders. 29 Adiposity, smoking and ensuing atherosclerotic vascular changes promote systemic inflammatory activity, 30, 31 whereas physical activity has many positive consequences on muscle health including anti-inflammatory properties. 32 On the other hand, risk factors also predispose to clinical CVD and thereby to 'secondary' frailty. 33 Although frailty status predicted mortality after adjustment for diseases in our cohort, 19 frail men nevertheless had more CVD comorbidity. Our study has potential limitations. The cohort included only men with high social status and therefore generalization to other groups, for example women, should be done cautiously. Frailty status was not formally assessed in 1974, but all men were professionally active at that time, they did not have clinical diseases including CVD and diabetes, nor regular medications. We did not evaluate the participants clinically in 2000, and selfreport on prevalent diseases in 2000 was used for calculation of the Charlson comorbidity index. Also the definition of frailty was based on questionnaire data, specifically from the RAND-36. However, there is no strict consensus for defining frailty, and various definitions may be used, 4,10 also based on questionnaire data. 19, 34 Our criteria recognized 9.6% of men as frail, a figure quite similar to a recent and large epidemiological survey using modified Fried criteria. 8 But most importantly, the frailty criteria used in this study have been shown to be associated with future development of slower walking speed and mobility-disability, as well as powerfully predict mortality in our population. 19 We believe, therefore, that our results can be taken to satisfactorily reflect phenotypic frailty.
In conclusion, frailty is an important antecedent of disability and death in ageing societies and preventive efforts are often started too late. Our prospective findings emphasize the life course trajectory of frailty with especially obesity, but also with overall CAD risk. We suggest that frailty and disability therefore should be identified as important endpoints of midlife obesity and increased cardiovascular risk.
